{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "01",
                "@timestamp": "2022-11-01T18:44:05.000005-04:00",
                "@year": "2022",
                "@month": "11"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Chulalongkorn University",
                "xocs:funding-agency-acronym": "CU",
                "xocs:funding-agency": "Chulalongkorn University",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
            },
            "xocs:funding-addon-generated-timestamp": "2022-10-27T05:57:15.435Z",
            "xocs:funding-text": "This work was supported by the staff at the Antibody Research Unit, Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University. The illustrations and images were created with BioRender.com.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Interdisciplinary Program of Biomedical Sciences"},
                                {"$": "Graduate School"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "112245966"
                            },
                            "@affiliation-instance-id": "2019702117-02a027b52817e49d6b08da6b2ff9a6f5",
                            "ce:source-text": "Interdisciplinary Program of Biomedical Sciences, Graduate School, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "112245966"
                        },
                        "author": [
                            {
                                "ce:given-name": "Tanapati",
                                "preferred-name": {
                                    "ce:given-name": "Tanapati",
                                    "ce:initials": "T.",
                                    "ce:surname": "Phakham",
                                    "ce:indexed-name": "Phakham T."
                                },
                                "@author-instance-id": "2019702117-d2d603b8f51cb029d148eea9da4963ce",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Phakham",
                                "@auid": "57203458986",
                                "ce:indexed-name": "Phakham T."
                            },
                            {
                                "ce:given-name": "Chatikorn",
                                "preferred-name": {
                                    "ce:given-name": "Chatikorn",
                                    "ce:initials": "C.",
                                    "ce:surname": "Boonkrai",
                                    "ce:indexed-name": "Boonkrai C."
                                },
                                "@author-instance-id": "2019702117-3fe1ab1844c465158a7c2e65907aa134",
                                "@seq": "2",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Boonkrai",
                                "@auid": "55932979400",
                                "ce:indexed-name": "Boonkrai C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Systems Biology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "127930229"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2019702117-2b1fcf9cfcc6fae604fedf7b559c9d1a",
                            "ce:source-text": "Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "127930229"
                        },
                        "author": [
                            {
                                "ce:given-name": "Tanapati",
                                "preferred-name": {
                                    "ce:given-name": "Tanapati",
                                    "ce:initials": "T.",
                                    "ce:surname": "Phakham",
                                    "ce:indexed-name": "Phakham T."
                                },
                                "@author-instance-id": "2019702117-d2d603b8f51cb029d148eea9da4963ce",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Phakham",
                                "@auid": "57203458986",
                                "ce:indexed-name": "Phakham T."
                            },
                            {
                                "ce:given-name": "Chatikorn",
                                "preferred-name": {
                                    "ce:given-name": "Chatikorn",
                                    "ce:initials": "C.",
                                    "ce:surname": "Boonkrai",
                                    "ce:indexed-name": "Boonkrai C."
                                },
                                "@author-instance-id": "2019702117-3fe1ab1844c465158a7c2e65907aa134",
                                "@seq": "2",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Boonkrai",
                                "@auid": "55932979400",
                                "ce:indexed-name": "Boonkrai C."
                            },
                            {
                                "ce:given-name": "Tossapon",
                                "preferred-name": {
                                    "ce:given-name": "Tossapon",
                                    "ce:initials": "T.",
                                    "ce:surname": "Wongtangprasert",
                                    "ce:indexed-name": "Wongtangprasert T."
                                },
                                "@author-instance-id": "2019702117-724c78df126f1d8294a9ea20a43e0654",
                                "@seq": "3",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wongtangprasert",
                                "@auid": "56067405400",
                                "ce:indexed-name": "Wongtangprasert T."
                            },
                            {
                                "ce:given-name": "Thittaya",
                                "preferred-name": {
                                    "ce:given-name": "Thittaya",
                                    "ce:initials": "T.",
                                    "ce:surname": "Audomsun",
                                    "ce:indexed-name": "Audomsun T."
                                },
                                "@author-instance-id": "2019702117-b6a7e5a91a4e459ed9aab757b43f825e",
                                "@seq": "4",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Audomsun",
                                "@auid": "57934088800",
                                "ce:indexed-name": "Audomsun T."
                            },
                            {
                                "ce:given-name": "Chadaporn",
                                "preferred-name": {
                                    "ce:given-name": "Chadaporn",
                                    "ce:initials": "C.",
                                    "ce:surname": "Attakitbancha",
                                    "ce:indexed-name": "Attakitbancha C."
                                },
                                "@author-instance-id": "2019702117-246a629073f450103a749af3be5ae838",
                                "@seq": "5",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Attakitbancha",
                                "@auid": "57218338459",
                                "ce:indexed-name": "Attakitbancha C."
                            },
                            {
                                "ce:given-name": "Pijitra",
                                "preferred-name": {
                                    "ce:given-name": "Pijitra",
                                    "ce:initials": "P.",
                                    "ce:surname": "Saelao",
                                    "ce:indexed-name": "Saelao P."
                                },
                                "@author-instance-id": "2019702117-ae28a77b826b7f0f4b614b4615bb5f64",
                                "@seq": "6",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Saelao",
                                "@auid": "57934244600",
                                "ce:indexed-name": "Saelao P."
                            },
                            {
                                "ce:given-name": "Phijitra",
                                "preferred-name": {
                                    "ce:given-name": "Phijitra",
                                    "ce:initials": "P.",
                                    "ce:surname": "Muanwien",
                                    "ce:indexed-name": "Muanwien P."
                                },
                                "@author-instance-id": "2019702117-3336e6c89957c2cc7c80f613379dc6c6",
                                "@seq": "7",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Muanwien",
                                "@auid": "57311253400",
                                "ce:indexed-name": "Muanwien P."
                            },
                            {
                                "ce:given-name": "Trairak",
                                "preferred-name": {
                                    "ce:given-name": "Trairak",
                                    "ce:initials": "T.",
                                    "ce:surname": "Pisitkun",
                                    "ce:indexed-name": "Pisitkun T."
                                },
                                "@author-instance-id": "2019702117-e8e550fb7c4765c3e171e6fda67bc2bd",
                                "@seq": "10",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Pisitkun",
                                "@auid": "6507728111",
                                "ce:indexed-name": "Pisitkun T."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199584",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "The Excellence Chulalongkorn Comprehensive Cancer Center"},
                                {"$": "King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60199584"},
                                {"@afid": "60022183"}
                            ],
                            "@affiliation-instance-id": "2019702117-ca9800bf9f477545ed25a87bb168eefb",
                            "ce:source-text": "The Excellence Chulalongkorn Comprehensive Cancer Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Tossapon",
                            "preferred-name": {
                                "ce:given-name": "Tossapon",
                                "ce:initials": "T.",
                                "ce:surname": "Wongtangprasert",
                                "ce:indexed-name": "Wongtangprasert T."
                            },
                            "@author-instance-id": "2019702117-724c78df126f1d8294a9ea20a43e0654",
                            "@seq": "3",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wongtangprasert",
                            "@auid": "56067405400",
                            "ce:indexed-name": "Wongtangprasert T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "The Institute of Biotechnology and Genetic Engineering"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "104425781"
                            },
                            "@affiliation-instance-id": "2019702117-5a9304cb045f68145a3f444f085414bc",
                            "ce:source-text": "The Institute of Biotechnology and Genetic Engineering, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "104425781"
                        },
                        "author": [{
                            "ce:given-name": "Sarintip",
                            "preferred-name": {
                                "ce:given-name": "Sarintip",
                                "ce:initials": "S.",
                                "ce:surname": "Sooksai",
                                "ce:indexed-name": "Sooksai S."
                            },
                            "@author-instance-id": "2019702117-477c8bed974c11775a9fdf73e10afbdb",
                            "@seq": "8",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sooksai",
                            "@auid": "36025849300",
                            "ce:indexed-name": "Sooksai S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Cancer Immunotherapy Excellence Center"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "128758646"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2019702117-c7de25428a7a79aa06df2e7c8077881f",
                            "ce:source-text": "Cancer Immunotherapy Excellence Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "128758646"
                        },
                        "author": [
                            {
                                "ce:given-name": "Nattiya",
                                "preferred-name": {
                                    "ce:given-name": "Nattiya",
                                    "ce:initials": "N.",
                                    "ce:surname": "Hirankarn",
                                    "ce:indexed-name": "Hirankarn N."
                                },
                                "@author-instance-id": "2019702117-b9ef4de8a0fa367dbf09e74f2c4b863c",
                                "@seq": "9",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Hirankarn",
                                "@auid": "12783320200",
                                "ce:indexed-name": "Hirankarn N."
                            },
                            {
                                "ce:given-name": "Trairak",
                                "preferred-name": {
                                    "ce:given-name": "Trairak",
                                    "ce:initials": "T.",
                                    "ce:surname": "Pisitkun",
                                    "ce:indexed-name": "Pisitkun T."
                                },
                                "@author-instance-id": "2019702117-e8e550fb7c4765c3e171e6fda67bc2bd",
                                "@seq": "10",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Pisitkun",
                                "@auid": "6507728111",
                                "ce:indexed-name": "Pisitkun T."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Immunology and Immune Mediated Diseases"},
                                {"$": "Department of Microbiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183424"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2019702117-289fcb255de387749912f804b2cb1aa2",
                            "ce:source-text": "Center of Excellence in Immunology and Immune Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "103183424"
                        },
                        "author": [{
                            "ce:given-name": "Nattiya",
                            "preferred-name": {
                                "ce:given-name": "Nattiya",
                                "ce:initials": "N.",
                                "ce:surname": "Hirankarn",
                                "ce:indexed-name": "Hirankarn N."
                            },
                            "@author-instance-id": "2019702117-b9ef4de8a0fa367dbf09e74f2c4b863c",
                            "@seq": "9",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Hirankarn",
                            "@auid": "12783320200",
                            "ce:indexed-name": "Hirankarn N."
                        }]
                    }
                ],
                "citation-title": "Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development",
                "abstracts": "Â© 2022, The Author(s).Programmed cell death protein 1 (PD-1) plays a significant role in suppressing antitumor immune responses. Cancer treatment with immune checkpoint inhibitors (ICIs) targeting PD-1 has been approved to treat numerous cancers and is the backbone of cancer immunotherapy. Anti-PD-1 molecule is necessary for next-generation cancer immunotherapy to further improve clinical efficacy and safety as well as integrate into novel treatment combinations or platforms. We developed a highly efficient hybridoma generation and screening strategy to generate high-potency chimeric anti-PD-1 molecules. Using this strategy, we successfully generated several mouse hybridoma and mouse/human chimeric clones that produced high-affinity antibodies against human PD-1 with high-quality in vitro PD-1/PD-L1 binding blockade and T cell activation activities. The lead chimeric prototypes exhibited overall in vitro performance comparable to commercially available anti-PD-1 antibodies and could be qualified as promising therapeutic candidates for further development toward immuno-oncology applications.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Center of Excellence in Systems Biology"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Trairak",
                        "ce:initials": "T.",
                        "ce:surname": "Pisitkun",
                        "ce:indexed-name": "Pisitkun T."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://www.nature.com/srep/",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Scientific Reports",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "12",
                        "@issue": "1"
                    }},
                    "@type": "j",
                    "sourcetitle": "Scientific Reports",
                    "publicationdate": {
                        "month": "12",
                        "year": "2022",
                        "date-text": "December 2022",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Sci. Rep.",
                    "@country": "gbr",
                    "issn": {
                        "$": "20452322",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Nature Research"},
                    "article-number": "17792",
                    "@srcid": "21100200805"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": "1000"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MULT"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "nlm",
                        "chemical": [
                            {"chemical-name": "Antibodies, Monoclonal"},
                            {"chemical-name": "B7-H1 Antigen"},
                            {"chemical-name": "Immune Checkpoint Inhibitors"},
                            {"chemical-name": "Programmed Cell Death 1 Receptor"}
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This work was supported by the staff at the Antibody Research Unit, Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University. The illustrations and images were created with BioRender.com.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNSOC"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "26",
                    "@timestamp": "BST 16:55:34",
                    "@year": "2022",
                    "@month": "10"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2019702117",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "943705942",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2022447822",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20223111330",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20223709116",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2022123378",
                            "@idtype": "SNSOC"
                        },
                        {
                            "$": "20229025981374",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85140207288",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85140207288",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "639334018",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "36273231",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "298817299",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1038/s41598-022-20560-6"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "33",
                "reference": [
                    {
                        "ref-fulltext": "Marin-Acevedo, J. A., Soyano, A. E., Dholaria, B., Knutson, K. L. & Lou, Y. Cancer immunotherapy beyond immune checkpoint inhibitors. J. Hematol. Oncol. 11, 8. 10.1186/s13045-017-0552-6 (2018). DOI: 10.1186/s13045-017-0552-6",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cancer immunotherapy beyond immune checkpoint inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s13045-017-0552-6",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040457867",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "8"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Marin-Acevedo",
                                    "ce:indexed-name": "Marin-Acevedo J.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Soyano",
                                    "ce:indexed-name": "Soyano A.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Dholaria",
                                    "ce:indexed-name": "Dholaria B."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Knutson",
                                    "ce:indexed-name": "Knutson K.L."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Lou",
                                    "ce:indexed-name": "Lou Y."
                                }
                            ]},
                            "ref-sourcetitle": "J. Hematol. Oncol."
                        },
                        "ce:source-text": "Marin-Acevedo, J. A., Soyano, A. E., Dholaria, B., Knutson, K. L. & Lou, Y. Cancer immunotherapy beyond immune checkpoint inhibitors. J. Hematol. Oncol. 11, 8. 10.1186/s13045-017-0552-6 (2018). DOI: 10.1186/s13045-017-0552-6"
                    },
                    {
                        "ref-fulltext": "Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651\u2013668. 10.1038/s41577-020-0306-5 (2020). DOI: 10.1038/s41577-020-0306-5",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A guide to cancer immunotherapy: from T cell basic science to clinical practice"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41577-020-0306-5",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85084967467",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "651",
                                    "@last": "668"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Waldman",
                                    "ce:indexed-name": "Waldman A.D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Fritz",
                                    "ce:indexed-name": "Fritz J.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Lenardo",
                                    "ce:indexed-name": "Lenardo M.J."
                                }
                            ]},
                            "ref-sourcetitle": "Nat. Rev. Immunol."
                        },
                        "ce:source-text": "Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651\u2013668. 10.1038/s41577-020-0306-5 (2020). DOI: 10.1038/s41577-020-0306-5"
                    },
                    {
                        "ref-fulltext": "Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer. 12, 252\u2013264. 10.1038/nrc3239 (2012). DOI: 10.1038/nrc3239",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "The blockade of immune checkpoints in cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nrc3239",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84858766182",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "252",
                                    "@last": "264"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "D.M.",
                                "@_fa": "true",
                                "ce:surname": "Pardoll",
                                "ce:indexed-name": "Pardoll D.M."
                            }]},
                            "ref-sourcetitle": "Nat. Rev. Cancer."
                        },
                        "ce:source-text": "Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer. 12, 252\u2013264. 10.1038/nrc3239 (2012). DOI: 10.1038/nrc3239"
                    },
                    {
                        "ref-fulltext": "Hargadon, K. M., Johnson, C. E. & Williams, C. J. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors. Int. Immunopharmacol. 62, 29\u201339. 10.1016/j.intimp.2018.06.001 (2018). DOI: 10.1016/j.intimp.2018.06.001",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.intimp.2018.06.001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85049351361",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "62"},
                                "pagerange": {
                                    "@first": "29",
                                    "@last": "39"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Hargadon",
                                    "ce:indexed-name": "Hargadon K.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnson",
                                    "ce:indexed-name": "Johnson C.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Williams",
                                    "ce:indexed-name": "Williams C.J."
                                }
                            ]},
                            "ref-sourcetitle": "Int. Immunopharmacol."
                        },
                        "ce:source-text": "Hargadon, K. M., Johnson, C. E. & Williams, C. J. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors. Int. Immunopharmacol. 62, 29\u201339. 10.1016/j.intimp.2018.06.001 (2018). DOI: 10.1016/j.intimp.2018.06.001"
                    },
                    {
                        "ref-fulltext": "Vaddepally, R. K., Kharel, P., Pandey, R., Garje, R. & Chandra, A. B. Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence. Cancers 10.3390/cancers12030738 (2020). DOI: 10.3390/cancers12030738",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/cancers12030738",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85082456705",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Vaddepally",
                                    "ce:indexed-name": "Vaddepally R.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Kharel",
                                    "ce:indexed-name": "Kharel P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Pandey",
                                    "ce:indexed-name": "Pandey R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Garje",
                                    "ce:indexed-name": "Garje R."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Chandra",
                                    "ce:indexed-name": "Chandra A.B."
                                }
                            ]},
                            "ref-sourcetitle": "Cancers"
                        },
                        "ce:source-text": "Vaddepally, R. K., Kharel, P., Pandey, R., Garje, R. & Chandra, A. B. Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence. Cancers 10.3390/cancers12030738 (2020). DOI: 10.3390/cancers12030738"
                    },
                    {
                        "ref-fulltext": "Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355. 10.1126/science.aar4060 (2018). DOI: 10.1126/science.aar4060",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cancer immunotherapy using checkpoint blockade"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1126/science.aar4060",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85045378539",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "1350",
                                    "@last": "1355"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Ribas",
                                    "ce:indexed-name": "Ribas A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Wolchok",
                                    "ce:indexed-name": "Wolchok J.D."
                                }
                            ]},
                            "ref-sourcetitle": "Science"
                        },
                        "ce:source-text": "Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355. 10.1126/science.aar4060 (2018). DOI: 10.1126/science.aar4060"
                    },
                    {
                        "ref-fulltext": "Mullard, A. FDA approves 100th monoclonal antibody product. Nat. Rev. Drug Discov. 20, 491\u2013495. 10.1038/d41573-021-00079-7 (2021). DOI: 10.1038/d41573-021-00079-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "FDA approves 100th monoclonal antibody product"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/d41573-021-00079-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85111792542",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "491",
                                    "@last": "495"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Mullard",
                                "ce:indexed-name": "Mullard A."
                            }]},
                            "ref-sourcetitle": "Nat. Rev. Drug Discov."
                        },
                        "ce:source-text": "Mullard, A. FDA approves 100th monoclonal antibody product. Nat. Rev. Drug Discov. 20, 491\u2013495. 10.1038/d41573-021-00079-7 (2021). DOI: 10.1038/d41573-021-00079-7"
                    },
                    {
                        "ref-fulltext": "Drake, C. G. Combination immunotherapy approaches. Ann. Oncol. 10.1093/annonc/mds262 (2012). DOI: 10.1093/annonc/mds262",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Combination immunotherapy approaches"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mds262",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84865553173",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "C.G.",
                                "@_fa": "true",
                                "ce:surname": "Drake",
                                "ce:indexed-name": "Drake C.G."
                            }]},
                            "ref-sourcetitle": "Ann. Oncol."
                        },
                        "ce:source-text": "Drake, C. G. Combination immunotherapy approaches. Ann. Oncol. 10.1093/annonc/mds262 (2012). DOI: 10.1093/annonc/mds262"
                    },
                    {
                        "ref-fulltext": "Zhuo, M., Chi, Y. & Wang, Z. The adverse events associated with combination immunotherapy in cancers: Challenges and chances. Asia Pac. J. Clin. Oncol. 16, e154\u2013e159. 10.1111/ajco.13365 (2020). DOI: 10.1111/ajco.13365",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The adverse events associated with combination immunotherapy in cancers: Challenges and chances"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/ajco.13365",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089311579",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "e154",
                                    "@last": "e159"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhuo",
                                    "ce:indexed-name": "Zhuo M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Chi",
                                    "ce:indexed-name": "Chi Y."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang Z."
                                }
                            ]},
                            "ref-sourcetitle": "Asia Pac. J. Clin. Oncol."
                        },
                        "ce:source-text": "Zhuo, M., Chi, Y. & Wang, Z. The adverse events associated with combination immunotherapy in cancers: Challenges and chances. Asia Pac. J. Clin. Oncol. 16, e154\u2013e159. 10.1111/ajco.13365 (2020). DOI: 10.1111/ajco.13365"
                    },
                    {
                        "ref-fulltext": "Filin, I. Y., Solovyeva, V. V., Kitaeva, K. V., Rutland, C. S. & Rizvanov, A. A. Current trends in cancer immunotherapy. Biomedicines. 10.3390/biomedicines8120621 (2020). DOI: 10.3390/biomedicines8120621",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Current trends in cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/biomedicines8120621",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85097934015",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "I.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Filin",
                                    "ce:indexed-name": "Filin I.Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "V.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Solovyeva",
                                    "ce:indexed-name": "Solovyeva V.V."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Kitaeva",
                                    "ce:indexed-name": "Kitaeva K.V."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Rutland",
                                    "ce:indexed-name": "Rutland C.S."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Rizvanov",
                                    "ce:indexed-name": "Rizvanov A.A."
                                }
                            ]},
                            "ref-sourcetitle": "Biomedicines."
                        },
                        "ce:source-text": "Filin, I. Y., Solovyeva, V. V., Kitaeva, K. V., Rutland, C. S. & Rizvanov, A. A. Current trends in cancer immunotherapy. Biomedicines. 10.3390/biomedicines8120621 (2020). DOI: 10.3390/biomedicines8120621"
                    },
                    {
                        "ref-fulltext": "Elshiaty, M., Schindler, H. & Christopoulos, P. Principles and current clinical landscape of multispecific antibodies against cancer. Int. J. Mol. Sci. 10.3390/ijms22115632 (2021). DOI: 10.3390/ijms22115632",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Principles and current clinical landscape of multispecific antibodies against cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/ijms22115632",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85106437472",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Elshiaty",
                                    "ce:indexed-name": "Elshiaty M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Schindler",
                                    "ce:indexed-name": "Schindler H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Christopoulos",
                                    "ce:indexed-name": "Christopoulos P."
                                }
                            ]},
                            "ref-sourcetitle": "Int. J. Mol. Sci."
                        },
                        "ce:source-text": "Elshiaty, M., Schindler, H. & Christopoulos, P. Principles and current clinical landscape of multispecific antibodies against cancer. Int. J. Mol. Sci. 10.3390/ijms22115632 (2021). DOI: 10.3390/ijms22115632"
                    },
                    {
                        "ref-fulltext": "Kontermann, R. E. & Brinkmann, U. Bispecific antibodies. Drug Discov. Today 20, 838\u2013847. 10.1016/j.drudis.2015.02.008 (2015). DOI: 10.1016/j.drudis.2015.02.008",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Bispecific antibodies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.drudis.2015.02.008",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84936847342",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "838",
                                    "@last": "847"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Kontermann",
                                    "ce:indexed-name": "Kontermann R.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "U.",
                                    "@_fa": "true",
                                    "ce:surname": "Brinkmann",
                                    "ce:indexed-name": "Brinkmann U."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Discov. Today"
                        },
                        "ce:source-text": "Kontermann, R. E. & Brinkmann, U. Bispecific antibodies. Drug Discov. Today 20, 838\u2013847. 10.1016/j.drudis.2015.02.008 (2015). DOI: 10.1016/j.drudis.2015.02.008"
                    },
                    {
                        "ref-fulltext": "Rafiq, S. et al. Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scfv) immune checkpoint blockade. Blood 130, 842. 10.1182/blood.V130.Suppl_1.842.842 (2017). DOI: 10.1182/blood.V130.Suppl_1.842.842",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scfv) immune checkpoint blockade"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1182/blood.V130.Suppl_1.842.842",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85045524483",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "130"},
                                "pagerange": {"@first": "842"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Rafiq",
                                    "ce:indexed-name": "Rafiq S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Rafiq, S. et al. Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scfv) immune checkpoint blockade. Blood 130, 842. 10.1182/blood.V130.Suppl_1.842.842 (2017). DOI: 10.1182/blood.V130.Suppl_1.842.842"
                    },
                    {
                        "ref-fulltext": "Zhang, J. Y., Yan, Y. Y., Li, J. J., Adhikari, R. & Fu, L. W. PD-1/PD-L1 Based combinational cancer therapy: Icing on the cake. Front Pharmacol 11, 722. 10.3389/fphar.2020.00722 (2020). DOI: 10.3389/fphar.2020.00722",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "PD-1/PD-L1 Based combinational cancer therapy: Icing on the cake"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fphar.2020.00722",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085878458",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "722"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang J.Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Yan",
                                    "ce:indexed-name": "Yan Y.Y."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li J.J."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Adhikari",
                                    "ce:indexed-name": "Adhikari R."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "L.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Fu",
                                    "ce:indexed-name": "Fu L.W."
                                }
                            ]},
                            "ref-sourcetitle": "Front Pharmacol"
                        },
                        "ce:source-text": "Zhang, J. Y., Yan, Y. Y., Li, J. J., Adhikari, R. & Fu, L. W. PD-1/PD-L1 Based combinational cancer therapy: Icing on the cake. Front Pharmacol 11, 722. 10.3389/fphar.2020.00722 (2020). DOI: 10.3389/fphar.2020.00722"
                    },
                    {
                        "ref-fulltext": "Tolcher, A. W. et al. Phase Ib study of utomilumab (PF-05082566), a 4\u20131BB/CD137 agonist, in combination with pembrolizumab (MK-3475) in patients with advanced solid tumors. Clin. Cancer Res. 23, 5349\u20135357. 10.1158/1078-0432.CCR-17-1243 (2017). DOI: 10.1158/1078-0432.CCR-17-1243",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Phase Ib study of utomilumab (PF-05082566), a 4\u20131BB/CD137 agonist, in combination with pembrolizumab (MK-3475) in patients with advanced solid tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.CCR-17-1243",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85029504106",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "5349",
                                    "@last": "5357"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Tolcher",
                                    "ce:indexed-name": "Tolcher A.W."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Tolcher, A. W. et al. Phase Ib study of utomilumab (PF-05082566), a 4\u20131BB/CD137 agonist, in combination with pembrolizumab (MK-3475) in patients with advanced solid tumors. Clin. Cancer Res. 23, 5349\u20135357. 10.1158/1078-0432.CCR-17-1243 (2017). DOI: 10.1158/1078-0432.CCR-17-1243"
                    },
                    {
                        "ref-fulltext": "Burova, E. et al. Preclinical development of the anti-LAG-3 antibody REGN3767: Characterization and activity in combination with the Anti-PD-1 antibody cemiplimab in human PD-1xLAG-3-knockin mice. Mol. Cancer Ther. 18, 2051\u20132062. 10.1158/1535-7163.Mct-18-1376 (2019). DOI: 10.1158/1535-7163.Mct-18-1376",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Preclinical development of the anti-LAG-3 antibody REGN3767: Characterization and activity in combination with the Anti-PD-1 antibody cemiplimab in human PD-1xLAG-3-knockin mice"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1535-7163.Mct-18-1376",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073531455",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "2051",
                                    "@last": "2062"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Burova",
                                    "ce:indexed-name": "Burova E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol. Cancer Ther."
                        },
                        "ce:source-text": "Burova, E. et al. Preclinical development of the anti-LAG-3 antibody REGN3767: Characterization and activity in combination with the Anti-PD-1 antibody cemiplimab in human PD-1xLAG-3-knockin mice. Mol. Cancer Ther. 18, 2051\u20132062. 10.1158/1535-7163.Mct-18-1376 (2019). DOI: 10.1158/1535-7163.Mct-18-1376"
                    },
                    {
                        "ref-fulltext": "Gellrich, F. F., Schmitz, M., Beissert, S. & Meier, F. Anti-PD-1 and novel combinations in the treatment of melanoma-an update. J. clin. Med. 10.3390/jcm9010223 (2020). DOI: 10.3390/jcm9010223",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Anti-PD-1 and novel combinations in the treatment of melanoma-an update"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/jcm9010223",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85082798871",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Gellrich",
                                    "ce:indexed-name": "Gellrich F.F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Schmitz",
                                    "ce:indexed-name": "Schmitz M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Beissert",
                                    "ce:indexed-name": "Beissert S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Meier",
                                    "ce:indexed-name": "Meier F."
                                }
                            ]},
                            "ref-sourcetitle": "J. clin. Med."
                        },
                        "ce:source-text": "Gellrich, F. F., Schmitz, M., Beissert, S. & Meier, F. Anti-PD-1 and novel combinations in the treatment of melanoma-an update. J. clin. Med. 10.3390/jcm9010223 (2020). DOI: 10.3390/jcm9010223"
                    },
                    {
                        "ref-fulltext": "Gu, C.-L. et al. Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition. Acta Pharmacol. Sin. 10.1038/s41401-021-00683-8 (2021). DOI: 10.1038/s41401-021-00683-8",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41401-021-00683-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85105824380",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.-L.",
                                    "@_fa": "true",
                                    "ce:surname": "Gu",
                                    "ce:indexed-name": "Gu C.-L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Acta Pharmacol. Sin."
                        },
                        "ce:source-text": "Gu, C.-L. et al. Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition. Acta Pharmacol. Sin. 10.1038/s41401-021-00683-8 (2021). DOI: 10.1038/s41401-021-00683-8"
                    },
                    {
                        "ref-fulltext": "Li, L. et al. Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing. Transl. Oncol. 14, 100916. 10.1016/j.tranon.2020.100916 (2021). DOI: 10.1016/j.tranon.2020.100916",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.tranon.2020.100916",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "100916",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85093680175",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "14"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transl. Oncol."
                        },
                        "ce:source-text": "Li, L. et al. Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing. Transl. Oncol. 14, 100916. 10.1016/j.tranon.2020.100916 (2021). DOI: 10.1016/j.tranon.2020.100916"
                    },
                    {
                        "ref-fulltext": "Dovedi, S. J. et al. Design and efficacy of a monovalent bispecific PD-1/CTLA4 antibody that enhances CTLA4 blockade on PD-1(+) activated T cells. Cancer Discov. 11, 1100\u20131117. 10.1158/2159-8290.Cd-20-1445 (2021). DOI: 10.1158/2159-8290.Cd-20-1445",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Design and efficacy of a monovalent bispecific PD-1/CTLA4 antibody that enhances CTLA4 blockade on PD-1(+) activated T cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/2159-8290.Cd-20-1445",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85106050234",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "1100",
                                    "@last": "1117"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Dovedi",
                                    "ce:indexed-name": "Dovedi S.J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Discov."
                        },
                        "ce:source-text": "Dovedi, S. J. et al. Design and efficacy of a monovalent bispecific PD-1/CTLA4 antibody that enhances CTLA4 blockade on PD-1(+) activated T cells. Cancer Discov. 11, 1100\u20131117. 10.1158/2159-8290.Cd-20-1445 (2021). DOI: 10.1158/2159-8290.Cd-20-1445"
                    },
                    {
                        "ref-fulltext": "Ingles Garces, A. H., Au, L., Mason, R., Thomas, J. & Larkin, J. Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer. Expert Opin. Inv. drugs 28, 695\u2013708. 10.1080/13543784.2019.1649657 (2019). DOI: 10.1080/13543784.2019.1649657",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/13543784.2019.1649657",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85070516697",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "695",
                                    "@last": "708"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Ingles Garces",
                                    "ce:indexed-name": "Ingles Garces A.H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Au",
                                    "ce:indexed-name": "Au L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Mason",
                                    "ce:indexed-name": "Mason R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Thomas",
                                    "ce:indexed-name": "Thomas J."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Larkin",
                                    "ce:indexed-name": "Larkin J."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Opin. Inv. drugs"
                        },
                        "ce:source-text": "Ingles Garces, A. H., Au, L., Mason, R., Thomas, J. & Larkin, J. Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer. Expert Opin. Inv. drugs 28, 695\u2013708. 10.1080/13543784.2019.1649657 (2019). DOI: 10.1080/13543784.2019.1649657"
                    },
                    {
                        "ref-fulltext": "Chamoto, K., Hatae, R. & Honjo, T. Current issues and perspectives in PD-1 blockade cancer immunotherapy. Int. J. Clin. Oncol. 25, 790\u2013800. 10.1007/s10147-019-01588-7 (2020). DOI: 10.1007/s10147-019-01588-7",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Current issues and perspectives in PD-1 blockade cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s10147-019-01588-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85077571790",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "790",
                                    "@last": "800"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Chamoto",
                                    "ce:indexed-name": "Chamoto K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Hatae",
                                    "ce:indexed-name": "Hatae R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Honjo",
                                    "ce:indexed-name": "Honjo T."
                                }
                            ]},
                            "ref-sourcetitle": "Int. J. Clin. Oncol."
                        },
                        "ce:source-text": "Chamoto, K., Hatae, R. & Honjo, T. Current issues and perspectives in PD-1 blockade cancer immunotherapy. Int. J. Clin. Oncol. 25, 790\u2013800. 10.1007/s10147-019-01588-7 (2020). DOI: 10.1007/s10147-019-01588-7"
                    },
                    {
                        "ref-fulltext": "Ahmed, S. R., Petersen, E., Patel, R. & Migden, M. R. Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma. Expert. Rev. Clin. Pharmacol. 12, 947\u2013951. 10.1080/17512433.2019.1665026 (2019). DOI: 10.1080/17512433.2019.1665026",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/17512433.2019.1665026",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073312955",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "947",
                                    "@last": "951"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Ahmed",
                                    "ce:indexed-name": "Ahmed S.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Petersen",
                                    "ce:indexed-name": "Petersen E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Migden",
                                    "ce:indexed-name": "Migden M.R."
                                }
                            ]},
                            "ref-sourcetitle": "Expert. Rev. Clin. Pharmacol."
                        },
                        "ce:source-text": "Ahmed, S. R., Petersen, E., Patel, R. & Migden, M. R. Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma. Expert. Rev. Clin. Pharmacol. 12, 947\u2013951. 10.1080/17512433.2019.1665026 (2019). DOI: 10.1080/17512433.2019.1665026"
                    },
                    {
                        "ref-fulltext": "Kaplon, H. & Reichert, J. M. Antibodies to watch in 2021. MAbs 13, 1860476. 10.1080/19420862.2020.1860476 (2021). DOI: 10.1080/19420862.2020.1860476",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Antibodies to watch in 2021"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/19420862.2020.1860476",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85099680665",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {"@first": "1860476"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Kaplon",
                                    "ce:indexed-name": "Kaplon H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Reichert",
                                    "ce:indexed-name": "Reichert J.M."
                                }
                            ]},
                            "ref-sourcetitle": "MAbs"
                        },
                        "ce:source-text": "Kaplon, H. & Reichert, J. M. Antibodies to watch in 2021. MAbs 13, 1860476. 10.1080/19420862.2020.1860476 (2021). DOI: 10.1080/19420862.2020.1860476"
                    },
                    {
                        "ref-fulltext": "Radomska, H. S. & Eckhardt, L. A. Mammalian cell fusion in an electroporation device. J. Immunol. Methods 188, 209\u2013217. 10.1016/0022-1759(95)00205-7 (1995). DOI: 10.1016/0022-1759(95)00205-7",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1995"},
                            "ref-title": {"ref-titletext": "Mammalian cell fusion in an electroporation device"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/0022-1759(95)00205-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0029610344",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "188"},
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "217"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Radomska",
                                    "ce:indexed-name": "Radomska H.S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Eckhardt",
                                    "ce:indexed-name": "Eckhardt L.A."
                                }
                            ]},
                            "ref-sourcetitle": "J. Immunol. Methods"
                        },
                        "ce:source-text": "Radomska, H. S. & Eckhardt, L. A. Mammalian cell fusion in an electroporation device. J. Immunol. Methods 188, 209\u2013217. 10.1016/0022-1759(95)00205-7 (1995). DOI: 10.1016/0022-1759(95)00205-7"
                    },
                    {
                        "ref-fulltext": "Yu, X., McGraw, P. A., House, F. S. & Crowe, J. E. Jr. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J. Immunol. Methods 336, 142\u2013151. 10.1016/j.jim.2008.04.008 (2008). DOI: 10.1016/j.jim.2008.04.008",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jim.2008.04.008",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "46149113910",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "336"},
                                "pagerange": {
                                    "@first": "142",
                                    "@last": "151"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.A.",
                                    "@_fa": "true",
                                    "ce:surname": "McGraw",
                                    "ce:indexed-name": "McGraw P.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.S.",
                                    "@_fa": "true",
                                    "ce:surname": "House",
                                    "ce:indexed-name": "House F.S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Crowe",
                                    "ce:suffix": "Jr.",
                                    "ce:indexed-name": "Crowe J.E."
                                }
                            ]},
                            "ref-sourcetitle": "J. Immunol. Methods"
                        },
                        "ce:source-text": "Yu, X., McGraw, P. A., House, F. S. & Crowe, J. E. Jr. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J. Immunol. Methods 336, 142\u2013151. 10.1016/j.jim.2008.04.008 (2008). DOI: 10.1016/j.jim.2008.04.008"
                    },
                    {
                        "ref-fulltext": "Hawksworth, D. & Tyner, J. Evaluation of adjuvant regimens for antibody development in rabbits (36.29). J. Immunol. 178, S17\u2013S18 (2007).",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Evaluation of adjuvant regimens for antibody development in rabbits (36.29)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058718610",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "178"},
                                "pagerange": {
                                    "@first": "S17",
                                    "@last": "S18"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Hawksworth",
                                    "ce:indexed-name": "Hawksworth D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Tyner",
                                    "ce:indexed-name": "Tyner J."
                                }
                            ]},
                            "ref-sourcetitle": "J. Immunol."
                        },
                        "ce:source-text": "Hawksworth, D. & Tyner, J. Evaluation of adjuvant regimens for antibody development in rabbits (36.29). J. Immunol. 178, S17\u2013S18 (2007)."
                    },
                    {
                        "ref-fulltext": "Rose, N. et al. Generation of monoclonal antibodies against native viral proteins using antigen-expressing mammalian cells for mouse immunization. BMC Biotechnol. 16, 83. 10.1186/s12896-016-0314-5 (2016). DOI: 10.1186/s12896-016-0314-5",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Generation of monoclonal antibodies against native viral proteins using antigen-expressing mammalian cells for mouse immunization"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s12896-016-0314-5",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84997235958",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {"@first": "83"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Rose",
                                    "ce:indexed-name": "Rose N."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Biotechnol."
                        },
                        "ce:source-text": "Rose, N. et al. Generation of monoclonal antibodies against native viral proteins using antigen-expressing mammalian cells for mouse immunization. BMC Biotechnol. 16, 83. 10.1186/s12896-016-0314-5 (2016). DOI: 10.1186/s12896-016-0314-5"
                    },
                    {
                        "ref-fulltext": "Techawiwattanaboon, T. et al. A Comparison of intramuscular and subcutaneous administration of ligA subunit vaccine adjuvanted with neutral liposomal formulation containing monophosphoryl lipid A and QS21. Vaccines. 10.3390/vaccines8030494 (2020). DOI: 10.3390/vaccines8030494",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A Comparison of intramuscular and subcutaneous administration of ligA subunit vaccine adjuvanted with neutral liposomal formulation containing monophosphoryl lipid A and QS21"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/vaccines8030494",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85090529923",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Techawiwattanaboon",
                                    "ce:indexed-name": "Techawiwattanaboon T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccines."
                        },
                        "ce:source-text": "Techawiwattanaboon, T. et al. A Comparison of intramuscular and subcutaneous administration of ligA subunit vaccine adjuvanted with neutral liposomal formulation containing monophosphoryl lipid A and QS21. Vaccines. 10.3390/vaccines8030494 (2020). DOI: 10.3390/vaccines8030494"
                    },
                    {
                        "ref-fulltext": "Zhang, P., Andorko, J. I. & Jewell, C. M. Impact of dose, route, and composition on the immunogenicity of immune polyelectrolyte multilayers delivered on gold templates. Biotechnol. Bioeng. 114, 423\u2013431. 10.1002/bit.26083 (2017). DOI: 10.1002/bit.26083",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Impact of dose, route, and composition on the immunogenicity of immune polyelectrolyte multilayers delivered on gold templates"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/bit.26083",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85006742115",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "114"},
                                "pagerange": {
                                    "@first": "423",
                                    "@last": "431"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.I.",
                                    "@_fa": "true",
                                    "ce:surname": "Andorko",
                                    "ce:indexed-name": "Andorko J.I."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Jewell",
                                    "ce:indexed-name": "Jewell C.M."
                                }
                            ]},
                            "ref-sourcetitle": "Biotechnol. Bioeng."
                        },
                        "ce:source-text": "Zhang, P., Andorko, J. I. & Jewell, C. M. Impact of dose, route, and composition on the immunogenicity of immune polyelectrolyte multilayers delivered on gold templates. Biotechnol. Bioeng. 114, 423\u2013431. 10.1002/bit.26083 (2017). DOI: 10.1002/bit.26083"
                    },
                    {
                        "ref-fulltext": "Percival-Alwyn, J. L. et al. Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope \u201ctags\u201d. MAbs 7, 129\u2013137. 10.4161/19420862.2014.985489 (2015). DOI: 10.4161/19420862.2014.985489",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope \"tags\""},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.4161/19420862.2014.985489",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84921389525",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "129",
                                    "@last": "137"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Percival-Alwyn",
                                    "ce:indexed-name": "Percival-Alwyn J.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "MAbs"
                        },
                        "ce:source-text": "Percival-Alwyn, J. L. et al. Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope \u201ctags\u201d. MAbs 7, 129\u2013137. 10.4161/19420862.2014.985489 (2015). DOI: 10.4161/19420862.2014.985489"
                    },
                    {
                        "ref-fulltext": "Phakham, T. et al. Functional characterization of pembrolizumab produced in nicotiana benthamiana using a rapid transient expression system. Front. plant sci. 10.3389/fpls.2021.736299 (2021). DOI: 10.3389/fpls.2021.736299",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Functional characterization of pembrolizumab produced in nicotiana benthamiana using a rapid transient expression system"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fpls.2021.736299",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85115646070",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Phakham",
                                    "ce:indexed-name": "Phakham T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front. plant sci."
                        },
                        "ce:source-text": "Phakham, T. et al. Functional characterization of pembrolizumab produced in nicotiana benthamiana using a rapid transient expression system. Front. plant sci. 10.3389/fpls.2021.736299 (2021). DOI: 10.3389/fpls.2021.736299"
                    },
                    {
                        "ref-fulltext": "Meyer, L. et al. A simplified workflow for monoclonal antibody sequencing. PLoS ONE 14, e0218717. 10.1371/journal.pone.0218717 (2019). DOI: 10.1371/journal.pone.0218717",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "A simplified workflow for monoclonal antibody sequencing"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0218717",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e0218717",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85067628978",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "14"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Meyer",
                                    "ce:indexed-name": "Meyer L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS ONE"
                        },
                        "ce:source-text": "Meyer, L. et al. A simplified workflow for monoclonal antibody sequencing. PLoS ONE 14, e0218717. 10.1371/journal.pone.0218717 (2019). DOI: 10.1371/journal.pone.0218717"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199584",
            "affilname": "Chulalongkorn Cancer Immunotherapy Excellence Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199584",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85140207288",
        "dc:description": "Programmed cell death protein 1 (PD-1) plays a significant role in suppressing antitumor immune responses. Cancer treatment with immune checkpoint inhibitors (ICIs) targeting PD-1 has been approved to treat numerous cancers and is the backbone of cancer immunotherapy. Anti-PD-1 molecule is necessary for next-generation cancer immunotherapy to further improve clinical efficacy and safety as well as integrate into novel treatment combinations or platforms. We developed a highly efficient hybridoma generation and screening strategy to generate high-potency chimeric anti-PD-1 molecules. Using this strategy, we successfully generated several mouse hybridoma and mouse/human chimeric clones that produced high-affinity antibodies against human PD-1 with high-quality in vitro PD-1/PD-L1 binding blockade and T cell activation activities. The lead chimeric prototypes exhibited overall in vitro performance comparable to commercially available anti-PD-1 antibodies and could be qualified as promising therapeutic candidates for further development toward immuno-oncology applications.",
        "pubmed-id": "36273231",
        "prism:coverDate": "2022-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85140207288",
        "dc:creator": {"author": [{
            "ce:given-name": "Tanapati",
            "preferred-name": {
                "ce:given-name": "Tanapati",
                "ce:initials": "T.",
                "ce:surname": "Phakham",
                "ce:indexed-name": "Phakham T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Phakham",
            "@auid": "57203458986",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203458986",
            "ce:indexed-name": "Phakham T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85140207288"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85140207288&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85140207288&origin=inward"
            }
        ],
        "source-id": "21100200805",
        "citedby-count": "2",
        "prism:volume": "12",
        "subtype": "ar",
        "dc:title": "Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development",
        "openaccess": "1",
        "prism:issn": "20452322",
        "publishercopyright": "Â© 2022, The Author(s).",
        "article-number": "17792",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Scientific Reports",
        "openaccessFlag": "true",
        "prism:doi": "10.1038/s41598-022-20560-6",
        "dc:identifier": "SCOPUS_ID:85140207288",
        "dc:publisher": "Nature Research"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Animals",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antibodies, Monoclonal",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "B7-H1 Antigen",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hybridomas",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Immune Checkpoint Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Immunotherapy",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Mice",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Programmed Cell Death 1 Receptor",
            "@weight": "a",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Multidisciplinary",
        "@code": "1000",
        "@abbrev": "MULT"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Tanapati",
            "preferred-name": {
                "ce:given-name": "Tanapati",
                "ce:initials": "T.",
                "ce:surname": "Phakham",
                "ce:indexed-name": "Phakham T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Phakham",
            "@auid": "57203458986",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203458986",
            "ce:indexed-name": "Phakham T."
        },
        {
            "ce:given-name": "Chatikorn",
            "preferred-name": {
                "ce:given-name": "Chatikorn",
                "ce:initials": "C.",
                "ce:surname": "Boonkrai",
                "ce:indexed-name": "Boonkrai C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Boonkrai",
            "@auid": "55932979400",
            "author-url": "https://api.elsevier.com/content/author/author_id/55932979400",
            "ce:indexed-name": "Boonkrai C."
        },
        {
            "ce:given-name": "Tossapon",
            "preferred-name": {
                "ce:given-name": "Tossapon",
                "ce:initials": "T.",
                "ce:surname": "Wongtangprasert",
                "ce:indexed-name": "Wongtangprasert T."
            },
            "@seq": "3",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60199584",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199584"
                }
            ],
            "ce:surname": "Wongtangprasert",
            "@auid": "56067405400",
            "author-url": "https://api.elsevier.com/content/author/author_id/56067405400",
            "ce:indexed-name": "Wongtangprasert T."
        },
        {
            "ce:given-name": "Thittaya",
            "preferred-name": {
                "ce:given-name": "Thittaya",
                "ce:initials": "T.",
                "ce:surname": "Audomsun",
                "ce:indexed-name": "Audomsun T."
            },
            "@seq": "4",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Audomsun",
            "@auid": "57934088800",
            "author-url": "https://api.elsevier.com/content/author/author_id/57934088800",
            "ce:indexed-name": "Audomsun T."
        },
        {
            "ce:given-name": "Chadaporn",
            "preferred-name": {
                "ce:given-name": "Chadaporn",
                "ce:initials": "C.",
                "ce:surname": "Attakitbancha",
                "ce:indexed-name": "Attakitbancha C."
            },
            "@seq": "5",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Attakitbancha",
            "@auid": "57218338459",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218338459",
            "ce:indexed-name": "Attakitbancha C."
        },
        {
            "ce:given-name": "Pijitra",
            "preferred-name": {
                "ce:given-name": "Pijitra",
                "ce:initials": "P.",
                "ce:surname": "Saelao",
                "ce:indexed-name": "Saelao P."
            },
            "@seq": "6",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Saelao",
            "@auid": "57934244600",
            "author-url": "https://api.elsevier.com/content/author/author_id/57934244600",
            "ce:indexed-name": "Saelao P."
        },
        {
            "ce:given-name": "Phijitra",
            "preferred-name": {
                "ce:given-name": "Phijitra",
                "ce:initials": "P.",
                "ce:surname": "Muanwien",
                "ce:indexed-name": "Muanwien P."
            },
            "@seq": "7",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Muanwien",
            "@auid": "57311253400",
            "author-url": "https://api.elsevier.com/content/author/author_id/57311253400",
            "ce:indexed-name": "Muanwien P."
        },
        {
            "ce:given-name": "Sarintip",
            "preferred-name": {
                "ce:given-name": "Sarintip",
                "ce:initials": "S.",
                "ce:surname": "Sooksai",
                "ce:indexed-name": "Sooksai S."
            },
            "@seq": "8",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Sooksai",
            "@auid": "36025849300",
            "author-url": "https://api.elsevier.com/content/author/author_id/36025849300",
            "ce:indexed-name": "Sooksai S."
        },
        {
            "ce:given-name": "Nattiya",
            "preferred-name": {
                "ce:given-name": "Nattiya",
                "ce:initials": "N.",
                "ce:surname": "Hirankarn",
                "ce:indexed-name": "Hirankarn N."
            },
            "@seq": "9",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Hirankarn",
            "@auid": "12783320200",
            "author-url": "https://api.elsevier.com/content/author/author_id/12783320200",
            "ce:indexed-name": "Hirankarn N."
        },
        {
            "ce:given-name": "Trairak",
            "preferred-name": {
                "ce:given-name": "Trairak",
                "ce:initials": "T.",
                "ce:surname": "Pisitkun",
                "ce:indexed-name": "Pisitkun T."
            },
            "@seq": "10",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Pisitkun",
            "@auid": "6507728111",
            "author-url": "https://api.elsevier.com/content/author/author_id/6507728111",
            "ce:indexed-name": "Pisitkun T."
        }
    ]}
}}